The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 24, 2016
Filed:
May. 15, 2012
Applicants:
Takashi Kobunai, Tokyo, JP;
Hitoshi Saito, Tokushima, JP;
Teiji Takechi, Tokyo, JP;
Inventors:
Assignee:
TAIHO PHARMACEUTICAL CO., LTD., Tokyo, JP;
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/395 (2006.01); G01N 33/574 (2006.01); C12Q 1/68 (2006.01); A61K 45/06 (2006.01); A61K 31/4412 (2006.01); A61K 31/513 (2006.01); A61K 31/53 (2006.01); C07K 16/28 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
A61K 39/39558 (2013.01); A61K 31/4412 (2013.01); A61K 31/513 (2013.01); A61K 31/53 (2013.01); A61K 45/06 (2013.01); C07K 16/2863 (2013.01); C12Q 1/6886 (2013.01); G01N 33/57446 (2013.01); A61K 2039/505 (2013.01); C12Q 2600/106 (2013.01); C12Q 2600/158 (2013.01); G01N 2333/485 (2013.01); G01N 2800/52 (2013.01);
Abstract
A method for predicting a therapeutic effect of chemotherapy with a combination drug containing tegafur, gimeracil, and oteracil potassium in a gastric cancer patient by:
Kobunai, Takashi. (2016). Method for selecting chemotherapy for gastric cancer patient using combination drug of tegafur, gimeracil and oteracil potassium and egfr inhibitor (U.S. Patent No. 9345767). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/9345767
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile